Drug Profile
Research programme: human papillomavirus antibodies - Biolex
Alternative Names: Anti-HPV antibody research programme - Biolex; Human papillomavirus antibody research programme - BiolexLatest Information Update: 01 Oct 2012
Price :
$50
*
At a glance
- Originator Biolex
- Class Monoclonal antibodies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Human papillomavirus infections